Table 2. Medical therapy.
| All, n = 8,342 | Quartile 1, n = 2,046 | Quartile 2, n = 1,899 | Quartile 3, n = 2,090 | Quartile 4, n = 2,307 | p | |
|---|---|---|---|---|---|---|
| ACE inhibitor, n (%) | 3223 (52) | 733 (53) | 889 (50) | 828 (49) | 773 (52) | <0.0001 *†‡ |
| ARB, n (%) | 1504 (24) | 298 (21) | 426 (24) | 407 (25) | 373 (26) | 0.016 †‡ |
| Aldosteron-antagonist, n (%) | 577 (9) | 101 (7) | 122 (7) | 139 (9) | 215 (15) | <0.0001 †‡§¶# |
| Beta-blocker, n (%) | 4166 (67) | 954 (76) | 1194 (64) | 1086 (65) | 932 (63) | <0.0001 *†‡ |
| Statin, n (%) | 4706 (71) | 1080 (66) | 1420 (76) | 1207 (72) | 999 (68) | <0.0001 *†§¶# |
| Aspirin, n (%) | 7001 (98) | 1813 (99) | 1323 (98) | 1712 (97) | 1553 (98) | 0.004 †‡§ |
| P2Y12 inhibitor, n (%) | 7010 (98) | 1800 (98) | 1922 (98) | 1729 (98) | 1559 (98) | 0.926 |
| Dual antiplatelet therapy, n (%) | 6866 (96) | 1800 (98) | 1868 (95) | 1679 (95) | 1519 (95) | <0.0001 *†‡ |
| Calcium-channal blocker, n (%) | 1637 (26) | 291 (19) | 489 (27) | 438 (27) | 419 (29) | <0.0001 *†‡ |
| Nitrates, n (%) | 1326 (22) | 191 (13) | 351 (20) | 381 (25) | 403 (29) | <0.0001 *†‡§¶# |
Significant differences according to quartiles:
* = Q1 vs. Q2,
† = Q1 vs. Q3,
‡ = Q1 vs. Q4,
§ = Q2 vs. Q3,
¶ = Q2 vs. Q4,
# = Q3 vs. Q4.
Quartile 1 = <58 years;
Quartile 2 = 58–65 years;
Quartile 3 = 66–73 years;
Quartile 4 = >73 years.
Abbreviations:
ACE = angiotensin-converting-enzyme;
ARB = angiotensin receptor blocker;
p = p-value.